Incyte stock price
인사이트NASDAQ:INCY · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →Incyte last closed at $115.30 (-1.57%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is 14.9×. Its overall grade ranks 29 of 739 stocks in Healthcare.
About this company
Incyte last closed at $115.30 (-1.57%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 29/739
Valuation grade F
Related stocks
- NovartisCompetitor
JAK 억제제·면역질환 치료제 영역에서 주요 경쟁사
- PfizerCompetitor
면역·종양 분야에서 Incyte의 주요 경쟁사
- MerckCompetitor
항암제 시장에서 직접 경쟁하는 글로벌 제약사
ETFs holding this stock
iShares Genomics Immunology and Healthcare ETF · Strategas Global Policy Opportunities ETF · Invesco S and P 500 GARP ETF
Details →About Incyte
- What technical signals does Incyte (INCY) have?
- Incyte current technical signals: no active technical signal.
- Is Incyte a cup-and-handle pattern?
- No. Incyte has no valid Cup signal right now.
- What published figures are available for Incyte?
- Market cap: $22.64B. Trailing 12 months PER: 14.9×. Latest quarter PBR: 3.78×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Incyte, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).